CPT1A and asthma: Using primary BECs and Beas-2b cells, CPT1A-FAO was demonstrated to maintain superior barrier stability, secondary to its influence on mitochondrial regulatory and anti-inflammatory effects on HDM or Th1/Th2 cytokine-activated cells, which is a critical link in the progression of asthma.